A novel treatment of central serous chorioretinopathy with topical anti-inflammatory therapy

A 45-year-old Caucasian female with diagnosis of central serous chorioretinopathy (CSCR) did not improve on conventional observational approach. She was not willing to proceed with photocoagulation or photodynamic therapy. An unconventional approach of topical anti-inflammatory (ketorolac, dexamethasone and hydrocortisone) preparation was prescribed. The course of her CSCR responded well on this unconventional treatment, but relapsed on cessation or tapering of treatment. After 18 weeks of treatment with a gradual taper, her condition resolved. The present case highlights an alternative but unconventional treatment of CSCR with prolonged use of anti-inflammatories.

Medienart:

E-Artikel

Erscheinungsjahr:

2012

Erschienen:

2012

Enthalten in:

Zur Gesamtaufnahme - volume:2012

Enthalten in:

BMJ case reports - 2012(2012) vom: 03. Sept.

Sprache:

Englisch

Beteiligte Personen:

Chong, Chee-Foong [VerfasserIn]
Yang, David [VerfasserIn]
Pham, Thuan Q [VerfasserIn]
Liu, Henry [VerfasserIn]

Links:

Volltext

Themen:

7S5I7G3JQL
Anti-Inflammatory Agents
Case Reports
Dexamethasone
Hydrocortisone
Journal Article
Ketorolac
Ophthalmic Solutions
WI4X0X7BPJ
YZI5105V0L

Anmerkungen:

Date Completed 17.03.2013

Date Revised 11.11.2023

published: Electronic

Citation Status MEDLINE

doi:

10.1136/bcr-2012-006970

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM220753261